Abingdon Health Plc (AIM:ABDX)

Market Cap	47.86M +121.4%
Revenue (ttm)	9.57M +40.4%
Net Income	-3.24M
EPS	-0.01
Shares Out	435.07M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	48,324
Open	11.00
Previous Close	11.00
Day's Range	10.50 - 11.50
52-Week Range	5.50 - 13.00
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 9, 2026

About Abingdon Health

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom.

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2008
• Employees: 129
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ABDX

Financial Performance

In fiscal year 2025, Abingdon Health's revenue was 8.43 million, an increase of 37.39% compared to the previous year's 6.14 million. Losses were -3.42 million, 168.7% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 11, 2026

Data Sources Report a data error